Principles of antineoplastic drug development and pharmacology:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York [u.a.]
Dekker
1996
|
| Schriftenreihe: | Basic and clinical oncology
9 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XIV, 741 S. Ill., graph. Darst |
| ISBN: | 0824793145 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV010929943 | ||
| 003 | DE-604 | ||
| 007 | t| | ||
| 008 | 960904s1996 xx ad|| |||| 00||| eng d | ||
| 020 | |a 0824793145 |9 0-8247-9314-5 | ||
| 035 | |a (OCoLC)34640815 | ||
| 035 | |a (DE-599)BVBBV010929943 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 050 | 0 | |a RC271.C5 | |
| 082 | 0 | |a 616.99/4061 |2 20 | |
| 084 | |a XI 7000 |0 (DE-625)153024:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Principles of antineoplastic drug development and pharmacology |c ed. by Richard L. Schilsky ... |
| 264 | 1 | |a New York [u.a.] |b Dekker |c 1996 | |
| 300 | |a XIV, 741 S. |b Ill., graph. Darst | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Basic and clinical oncology |v 9 | |
| 650 | 7 | |a Anticancéreux |2 ram | |
| 650 | 2 | |a Antinéoplasiques - Pharmacologie | |
| 650 | 2 | |a Antinéoplasiques | |
| 650 | 7 | |a Cancer - Chimiothérapie |2 ram | |
| 650 | 2 | |a Conception de médicaments | |
| 650 | 7 | |a Geneesmiddelen |2 gtt | |
| 650 | 7 | |a Médicaments - Mise au point |2 ram | |
| 650 | 7 | |a Ontwikkeling (proces) |2 gtt | |
| 650 | 7 | |a Pharmocologie anticancéreuse |2 ram | |
| 650 | 7 | |a Tumoren |2 gtt | |
| 650 | 4 | |a Antineoplastic Agents |x pharmacology | |
| 650 | 4 | |a Antineoplastic agents |x Development | |
| 650 | 4 | |a Cancer |x Chemotherapy | |
| 650 | 4 | |a Drug Delivery Systems | |
| 650 | 4 | |a Drug Evaluation | |
| 650 | 4 | |a Drug Resistance, Neoplasm | |
| 650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 0 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Schilsky, Richard L. |e Sonstige |4 oth | |
| 830 | 0 | |a Basic and clinical oncology |v 9 |w (DE-604)BV006176602 |9 9 | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007311129&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-007311129 | |
Datensatz im Suchindex
| _version_ | 1823607493719228417 |
|---|---|
| adam_text |
PRINCIPLES OF ANTINEOPLASTIC DRUG DEVELOPMENT AND PHARMACOLOGY EDITED BY
RICHARD L. SCHILSKY CANCER RESEARCH CENTER UNIVERSITY OF CHICAGO
CHICAGO, ILLINOIS GERARD A. MILANO CENTRE ANTOINE-LACASSAGNE NICE,
FRANCE MARK J. RATAIN CANCER RESEARCH CENTER UNIVERSITY OF CHICAGO
CHICAGO, ILLINOIS MARCEL DEKKER, INC. NEW YORK* BASEL * HONG KONG
CONTENTS SERIES INTRODUCTION (BRUCE D. CHESON) HI PREFACE V CONTRIBUTORS
XI PART I. PRINCIPLES OF DRUG DEVELOPMENT 1. CANCER DRUG SCREENING 1
MICHAEL R. GREVER 2. THE HUMAN TUMOR-CLONING ASSAY 15 AXEL-R. HANAUSKE,
SUSAN G. HILSENBECK, AND DANIEL D. VON HOFF ' 3. PHASE I CLINICAL TRIAL
DESIGN 29 ROSEMARIE MICK 4. THE NEW DRUG APPROVAL PROCESS: CLINICAL AND
REGULATORY ASPECTS 37 RENZO CANETTA 5. DEVELOPMENT OF BIOLOGICAL AGENTS
55 ROSEMARY MAZANET, MARY ANN FOOTE, AND GEORGE MORSTYN PART II.
PRINCIPLES OF ANTINEOPIASTIC PHARMACOLOGY CLINICAL PHARMACOLOGY OF
ANTICANCEI B. W. BERRY AND CHARLES ERLICHMAN 6. CLINICAL PHARMACOLOGY OF
ANTICANCER DRUGS 75 VII VIII CONTENTS 7. PRINCIPLES OF PHARMACOKINETICS
AND PHARMACODYNAMICS 123 MARK J. RATAIN AND ROSEMARIE MICK 8.
BIOCHEMICAL MODULATION OF CANCER CHEMOTHERAPY 143 GEORGE A. SOTOS AND
CARMEN J. ALLEGRA 9. DRUG INTERACTIONS IN CANCER CHEMOTHERAPY 189
FRANGOIS LOKIEC 10. DRUG-RADIATION INTERACTIONS 203 EVERETT E. VOKES 11.
PRINCIPLES OF CHEMOTHERAPY INTERACTION WITH BIOLOGICAL AGENTS 223 MARIO
SZNOL, CHRISTINE L. CARTER, AND DAN L. LONGO 12. SHEMATOPOIETIC GROWTH
FACTORS AND CANCER CHEMOTHERAPY 241 MICHAEL S. GORDON 13. DOSE INTENSITY
263 WILLIAM M. HRYNIUK PART III. PRINCIPLES OF CHEMOTHERAPY DOSING 14.
POLYMORPHIC DRUG-METABOLIZING ENZYMES 281 ZHIHONG LU AND ROBERT B.
DIASIO 15. HUMAN CYTOCHROMES P-450 307 FRANK J. GONZALEZ 16. CELLULAR
PHARMACODYNAMICS OF ANTICANCER DRUGS 329 PETER J. O 'DWYER, THOMAS C.
HAMILTON, KANG-SHEN YAO, ROBERT F. OZOLS, AND JAMES M. GALLO 17. CANCER
CHEMOTHERAPY IN THE ELDERLY 363 MAURICE SCHNEIDER 18. CANCER
CHEMOTHERAPY AND PHARMACOLOGY IN CHILDREN 375 STEVEN WEITMAN AND BARTON
A. KAMEN 19. ADAPTIVE CONTROL OF DRUG DOSAGE REGIMENS: BASIC CONCEPTS,
RELEVANT ISSUES, AND CLINICAL APPLICATIONS 399 ROGER W. JELLIFFE 20.
INDIVIDUALIZED DOSING OF ANTICANCER DRUGS 435 ALAN V. BODDY AND A.
HILARY CALVERT PART IV. PRINCIPLES OF DRUG RESISTANCE T 21. MULTIDRUG
RESISTANCE 457 AHMAD R. SAFA CONTENTS IX 22. DNA TOPOISOMERASES AND
TUMOR CELL RESISTANCE TO THEIR INHIBITORS 487 WILLIAM T. BECK 23. THE
GLUTATHIONE SYSTEM AND DRUG RESISTANCE 503 GERALD BATIST, ROBYN L.
SCHECTER, AND MOULAY A. ALAOUI-JAMALI 24. IMPORTANCE OF DNA REPAIR IN
CANCER CHEMOTHERAPY 523 M. EILEEN DOLAN 25. RESISTANCE TO
ANTIMETABOLITES 543 GODEFRIDUS J. PETERS AND GERRIT JANSEN PART V.
.PRINCIPLES OF DRUG DELIVERY 26. TARGETED DRUG DELIVERY 587 PRAMOD K.
GUPTA, JOHN B. CANNON, AND ANIL KUMAR TIBREWAL 27. INTRA-ARTERIAL
CHEMOTHERAPY 617 WILLIAM D. ENSMINGER 28. INTRAPERITONEAL CHEMOTHERAPY
629 MAURIE MARKMAN 29. INTRATHECAL CHEMOTHERAPY 641 SUSAN M. BLANEY AND
DAVID G. POPLACK 30. SYSTEMIC INFUSIONAL CHEMOTHERAPY 661 JACOB J.
LOKICH AND NORWOOD ANDERSON 31. CIRCADIAN PHARMACODYNAMICS 681 WILLIAM
J. M. HRUSHESKY, ROBERT DE W. MARSH, AND PATRICIA A. WOOD INDEX 721 |
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV010929943 |
| callnumber-first | R - Medicine |
| callnumber-label | RC271 |
| callnumber-raw | RC271.C5 |
| callnumber-search | RC271.C5 |
| callnumber-sort | RC 3271 C5 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | XI 7000 |
| ctrlnum | (OCoLC)34640815 (DE-599)BVBBV010929943 |
| dewey-full | 616.99/4061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/4061 |
| dewey-search | 616.99/4061 |
| dewey-sort | 3616.99 44061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 cb4500</leader><controlfield tag="001">BV010929943</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">960904s1996 xx ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0824793145</subfield><subfield code="9">0-8247-9314-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)34640815</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010929943</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC271.C5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/4061</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 7000</subfield><subfield code="0">(DE-625)153024:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Principles of antineoplastic drug development and pharmacology</subfield><subfield code="c">ed. by Richard L. Schilsky ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York [u.a.]</subfield><subfield code="b">Dekker</subfield><subfield code="c">1996</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIV, 741 S.</subfield><subfield code="b">Ill., graph. Darst</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Basic and clinical oncology</subfield><subfield code="v">9</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anticancéreux</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Antinéoplasiques - Pharmacologie</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Antinéoplasiques</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer - Chimiothérapie</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Conception de médicaments</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Geneesmiddelen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Médicaments - Mise au point</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ontwikkeling (proces)</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmocologie anticancéreuse</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tumoren</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Agents</subfield><subfield code="x">pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic agents</subfield><subfield code="x">Development</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Delivery Systems</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Resistance, Neoplasm</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schilsky, Richard L.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Basic and clinical oncology</subfield><subfield code="v">9</subfield><subfield code="w">(DE-604)BV006176602</subfield><subfield code="9">9</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007311129&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007311129</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV010929943 |
| illustrated | Illustrated |
| indexdate | 2025-02-09T19:00:29Z |
| institution | BVB |
| isbn | 0824793145 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007311129 |
| oclc_num | 34640815 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | XIV, 741 S. Ill., graph. Darst |
| publishDate | 1996 |
| publishDateSearch | 1996 |
| publishDateSort | 1996 |
| publisher | Dekker |
| record_format | marc |
| series | Basic and clinical oncology |
| series2 | Basic and clinical oncology |
| spelling | Principles of antineoplastic drug development and pharmacology ed. by Richard L. Schilsky ... New York [u.a.] Dekker 1996 XIV, 741 S. Ill., graph. Darst txt rdacontent n rdamedia nc rdacarrier Basic and clinical oncology 9 Anticancéreux ram Antinéoplasiques - Pharmacologie Antinéoplasiques Cancer - Chimiothérapie ram Conception de médicaments Geneesmiddelen gtt Médicaments - Mise au point ram Ontwikkeling (proces) gtt Pharmocologie anticancéreuse ram Tumoren gtt Antineoplastic Agents pharmacology Antineoplastic agents Development Cancer Chemotherapy Drug Delivery Systems Drug Evaluation Drug Resistance, Neoplasm Cytostatikum (DE-588)4068347-3 gnd rswk-swf Pharmakologie (DE-588)4045687-0 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Cytostatikum (DE-588)4068347-3 s Pharmakologie (DE-588)4045687-0 s DE-604 Schilsky, Richard L. Sonstige oth Basic and clinical oncology 9 (DE-604)BV006176602 9 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007311129&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Principles of antineoplastic drug development and pharmacology Basic and clinical oncology Anticancéreux ram Antinéoplasiques - Pharmacologie Antinéoplasiques Cancer - Chimiothérapie ram Conception de médicaments Geneesmiddelen gtt Médicaments - Mise au point ram Ontwikkeling (proces) gtt Pharmocologie anticancéreuse ram Tumoren gtt Antineoplastic Agents pharmacology Antineoplastic agents Development Cancer Chemotherapy Drug Delivery Systems Drug Evaluation Drug Resistance, Neoplasm Cytostatikum (DE-588)4068347-3 gnd Pharmakologie (DE-588)4045687-0 gnd |
| subject_GND | (DE-588)4068347-3 (DE-588)4045687-0 (DE-588)4143413-4 |
| title | Principles of antineoplastic drug development and pharmacology |
| title_auth | Principles of antineoplastic drug development and pharmacology |
| title_exact_search | Principles of antineoplastic drug development and pharmacology |
| title_full | Principles of antineoplastic drug development and pharmacology ed. by Richard L. Schilsky ... |
| title_fullStr | Principles of antineoplastic drug development and pharmacology ed. by Richard L. Schilsky ... |
| title_full_unstemmed | Principles of antineoplastic drug development and pharmacology ed. by Richard L. Schilsky ... |
| title_short | Principles of antineoplastic drug development and pharmacology |
| title_sort | principles of antineoplastic drug development and pharmacology |
| topic | Anticancéreux ram Antinéoplasiques - Pharmacologie Antinéoplasiques Cancer - Chimiothérapie ram Conception de médicaments Geneesmiddelen gtt Médicaments - Mise au point ram Ontwikkeling (proces) gtt Pharmocologie anticancéreuse ram Tumoren gtt Antineoplastic Agents pharmacology Antineoplastic agents Development Cancer Chemotherapy Drug Delivery Systems Drug Evaluation Drug Resistance, Neoplasm Cytostatikum (DE-588)4068347-3 gnd Pharmakologie (DE-588)4045687-0 gnd |
| topic_facet | Anticancéreux Antinéoplasiques - Pharmacologie Antinéoplasiques Cancer - Chimiothérapie Conception de médicaments Geneesmiddelen Médicaments - Mise au point Ontwikkeling (proces) Pharmocologie anticancéreuse Tumoren Antineoplastic Agents pharmacology Antineoplastic agents Development Cancer Chemotherapy Drug Delivery Systems Drug Evaluation Drug Resistance, Neoplasm Cytostatikum Pharmakologie Aufsatzsammlung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007311129&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV006176602 |
| work_keys_str_mv | AT schilskyrichardl principlesofantineoplasticdrugdevelopmentandpharmacology |